QLT, Inc. (USA) (NASDAQ:QLTI)

CAPS Rating: 3 out of 5

A biopharmaceutical company dedicated to the discovery, development and commercialization of innovative therapies.

Recs

0
Player Avatar ethicalfool (73.07) Submitted: 8/31/2006 10:11:31 PM : Underperform Start Price: $7.69 QLTI Score: +8.81

Glad I sold before it went down even furthe

Report this Post Reply

Featured Broker Partners


Advertisement